Roivant Sciences Ltd. - Common Shares — 분기별 재무 통계 (NASDAQ:ROIV)

Financials

영업활동으로 인한 현금 -163.82 M -750.35 M 투자 활동으로 인한 현금 173.49 M -682.33 M 재무활동으로 인한 현금 -68.78 M 134.24 M 잉여 현금 흐름 -165.08 M -758.56 M

Roivant Sciences Ltd. - Common Shares

Roivant Sciences Ltd. is an American multinational healthcare company focused on applying technology to drug development and building subsidiary life sciences and health technology companies. It was founded in 2014 by Vivek Ramaswamy and is currently headed by CEO Matt Gline. Roivant maintains its headquarters in New York City as well as major offices in the biotech hubs of Boston and Basel.

ROIV

Financials

Roivant Sciences Ltd. - Common Shares

뉴스

Roivant Sciences Ltd. (ROIV) Presents at Bernstein 42nd Annual Strategic Decisions Conference Transcript

Roivant: Immunovant's Rheumatoid Arthritis Win Validates The Buy (NASDAQ:ROIV)

Roivant Sciences Ltd. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:ROIV) 2026-05-21

These Two Biotech Stocks Rocketed — And One Just Broke Out

Roivant Sciences Ltd. (ROIV) Reports Q4 Loss, Misses Revenue Estimates

Montes Archimedes Acquisition (ROIV) Upgraded to Buy: Here's Why

Gossamer Bio (GOSS) Reports Q1 Loss, Tops Revenue Estimates

Invivyd, Inc. (IVVD) Reports Q1 Loss, Lags Revenue Estimates

Roivant Sciences Ltd. (ROIV) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Fate Therapeutics (FATE) Reports Q1 Loss, Misses Revenue Estimates

Metagenomi Therapeutics (MGX) Reports Q1 Loss, Misses Revenue Estimates

Zealand Pharma A/S (ZLDPF) Reports Q1 Loss, Lags Revenue Estimates